Delivery Order SPE2DB20D3101-SPE2DB25FRMU0

Award Date 6/12/25
Potential Completion Date 6/13/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,189.34 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VYVANSE 30 MG CAPSULE 100S, a prescription medication, with a performance period extending through June 10, 2025. This delivery order is not set aside and represents open competition. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a $1,722.79 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,563,260,669 units of the drug VYVANSE 40 MG CAPSULE 100S. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a $1,570.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,567,887,307 units of the drug VYVANSE 50 MG CAPSULE 100S. The contract has an ultimate completion date of April 14, 2025 and was awarded on April 11, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,665.64 firm fixed-price contract is for the supply of 4,566,066,491 units of the pharmaceutical product VYVANSE 40 MG CAPSULE 100S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to...
This is a $15,212.33 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYVANSE 50 MG CAPSULE 100S, a medication, with a period of performance ending on March 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a $4,022.73 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract is set to expire on September 16, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military...
This is a $36,367.43 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYVANSE CAPS 50MG, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of March 27, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This is a $1,090.73 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,567,922,310 units of the drug VYVANSE 30 MG CAPSULE 100S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to...
This is a $2,063.21 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,566,893,245 units of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of January 13, 2025 and was awarded on January 10, 2025. The contract was not set aside for any specific business type....
This is a $4,465.82 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,242,894 units of the pharmaceutical product VYVANSE 20 MG CAPSULE 100S. The award has a completion date of July 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRMU0
    Delivery Order

This is a $1,180.96 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 100 units of the prescription medication VYVANSE 40 MG CAPSULE. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides global pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government agencies. The contract does not have a set-aside designation, indicating open competition. The award date is June 12, 2025, with a completion date of June 13, 2025.

Generated 9/11/25, 11:05 AM